GRI Bio Inc (GRI)

Name: GRI Bio Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-07-31

Latest Quarter

2025-07-31

Revenue

$0.0

Net Income

-$2.9M

Operating Margin

N/A

Free Cash Flow

-$10.2M

Debt / Assets

30.7%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for GRI Bio Inc (GRI).
Income Statement (Quarterly)	2025-07-31	2025-01-31	2024-12-31	2024-10-31
Revenue	0	2,298,000	0	0
Cost of Revenue	1,000	0	0	0
Gross Profit	-1,000	2,298,000	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,018,000	1,125,000	1,125,000	1,000,000
Operating Expenses	2,897,000	1,954,000	1,953,000	2,130,000
Operating Income	-2,897,000	-1,954,000	-1,953,000	-2,130,000
Interest Expense	0	0	0	0
Income Before Tax	-2,892,000	-1,948,000	-1,947,000	-2,123,000
Income Tax Expense	0	0	0	0
Net Income	-2,892,000	-1,948,000	-1,947,000	-2,123,000
Per Share
EPS	-1.31	-0.40	140.81	-11.42
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for GRI Bio Inc (GRI).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	0	22,538,000	0	0
Cost of Revenue	4,000	11,628,000	0	206,000
Gross Profit	-4,000	10,910,000	0	-206,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	5,158,000	4,467,000	8,155,000	1,997,000
Operating Expenses	11,977,000	8,235,000	11,387,000	2,239,000
Operating Income	-11,977,000	-8,235,000	-11,387,000	-2,239,000
Interest Expense	0	-6,000	2,082,000	653,000
Income Before Tax	-11,956,000	-8,207,000	-13,037,000	-3,217,000
Income Tax Expense	0	0	0	325,000
Net Income	-11,956,000	-8,207,000	-13,037,000	-3,542,000
Per Share
EPS	-121.80	-55.21	-6,242.18	-823.76
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for GRI Bio Inc (GRI).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	8,229,000	5,028,000	1,808,000	9,000
Short Term Investments	0	0	0	0
Net Receivables	0	0	0	0
Inventory	0	0	0	0
Total Current Assets	8,592,000	5,615,000	2,934,000	308,000
Property Plant Equipment	74,000	124,000	22,000	71,000
Goodwill and Intangibles	0	0	0	0
Total Assets	8,666,000	5,739,000	2,956,000	383,000
Liabilities
Account Payables	1,837,000	897,000	1,410,000	1,294,000
Short Term Debt	112,000	96,000	14,000	659,000
Total Current Liabilities	2,643,000	1,636,000	2,697,000	1,994,000
Long Term Debt	15,000	71,000	0	14,000
Total Liabilities	2,658,000	1,707,000	2,697,000	2,008,000
Shareholders Equity
Retained Earnings	-51,696,000	-39,740,000	-31,533,000	-18,496,000
Total Shareholders Equity	6,008,000	4,032,000	259,000	-1,625,000

Balance sheet annual history for GRI Bio Inc (GRI).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	8,229,000	5,028,000	1,808,000	9,000
Short Term Investments	0	0	0	0
Net Receivables	0	0	0	0
Inventory	0	0	0	0
Total Current Assets	8,592,000	5,615,000	2,934,000	308,000
Property Plant Equipment	74,000	124,000	22,000	71,000
Goodwill and Intangibles	0	0	0	0
Total Assets	8,666,000	5,739,000	2,956,000	383,000
Liabilities
Account Payables	1,837,000	897,000	1,410,000	1,294,000
Short Term Debt	112,000	96,000	14,000	659,000
Total Current Liabilities	2,643,000	1,636,000	2,697,000	1,994,000
Long Term Debt	15,000	71,000	0	14,000
Total Liabilities	2,658,000	1,707,000	2,697,000	2,008,000
Shareholders Equity
Retained Earnings	-51,696,000	-39,740,000	-31,533,000	-18,496,000
Total Shareholders Equity	6,008,000	4,032,000	259,000	-1,625,000

Cash flow quarterly history for GRI Bio Inc (GRI).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-11,956,000	-8,207,000	-13,037,000	-3,217,000
Depreciation & Amortization	4,000	4,000	57,000	50,000
Stock Based Compensation	793,000	0	388,000	25,000
Change in Working Capital	925,000	-448,000	1,680,000	1,515,000
Operating Cash Flow	-10,186,000	-8,611,000	-9,140,000	-1,085,000
Investing Activities
Capital Expenditure	-3,000	0	-8,000	-3,000
Investments	-3,000	-396,000	-8,000	-3,000
Investing Cash Flow	-3,000	0	-8,000	-3,000
Financing Activities
Debt Repayment	0	0	-1,250,000	-250,000
Common Stock Issued/Repurchased	15,559,000	13,102,000	11,745,000	3,323,000
Dividends Paid	0	0	-2,915,000	-3,447,000
Financing Cash Flow	13,390,000	11,831,000	10,947,000	1,007,000
Summary
Free Cash Flow	-10,189,000	-8,611,000	-9,148,000	-1,088,000
Net Change in Cash	3,201,000	3,220,000	1,799,000	-81,000

Cash flow annual history for GRI Bio Inc (GRI).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-11,956,000	-8,207,000	-13,037,000	-3,217,000
Depreciation & Amortization	4,000	4,000	57,000	50,000
Stock Based Compensation	793,000	0	388,000	25,000
Change in Working Capital	925,000	-448,000	1,680,000	1,515,000
Operating Cash Flow	-10,186,000	-8,611,000	-9,140,000	-1,085,000
Investing Activities
Capital Expenditure	-3,000	0	-8,000	-3,000
Investments	-3,000	-396,000	-8,000	-3,000
Investing Cash Flow	-3,000	0	-8,000	-3,000
Financing Activities
Debt Repayment	0	0	-1,250,000	-250,000
Common Stock Issued/Repurchased	15,559,000	13,102,000	11,745,000	3,323,000
Dividends Paid	0	0	-2,915,000	-3,447,000
Financing Cash Flow	13,390,000	11,831,000	10,947,000	1,007,000
Summary
Free Cash Flow	-10,189,000	-8,611,000	-9,148,000	-1,088,000
Net Change in Cash	3,201,000	3,220,000	1,799,000	-81,000